Physician profile
Robert Strominger
NPI 1447353529
$1,462.86
in general payments reported to CMS, 2019-2025
22 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $216 · 2021: $325 · 2022: $400 · 2023: $53.44 · 2024: $105 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $855.50 | 2019-2025 | Scopis Ent, Stryker Nav3 |
| My01 INC. | $143.16 | 2022 | |
| Atos Medical INC | $104.81 | 2024 | Provox Life Home Hme |
| Medtronic, INC. | $37.32 | 2023-2025 | Stealthstation S8 Platform |
| Karl Storz Endoscopy-America | $33.54 | 2019 | |
| Aerin Medical INC. | $23.92 | 2022 | |
| Genzyme Corporation | $22.54 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $20.93 | 2021 | |
| Abbvie INC. | $20.39 | 2023 | Ubrelvy |
| Intersect Ent, INC. | $20.19 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.90 | 2021 | |
| Dexcom, INC. | $19.03 | 2025 | Dexcom G6 Transmitter |
| Acera Surgical, INC. | $18.37 | 2020 | |
| Kci USA, INC. | $16.05 | 2021 | |
| Misonix INC | $15.46 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $14.33 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.83 | 2022 | |
| Ethicon US, LLC | $13.63 | 2022 | |
| Olympus America INC. | $13.08 | 2023 | Rhino-Laryngo Videoscope |
| Mylan Specialty L.P. | $12.48 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Strominger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.